The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 6, 2014, Pages 2152-2157

  Huard, Caroline C ^a   Tremblay, Cédric S ^a,c   Magron, Audrey ^a   Lévesque, Georges ^a,b   Carreau, Madeleine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84893846498     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1314226111     Document Type: Article

References (31)

1. Bagby GC, Lipton JM, Sloand EM, Schiffer CA (2004) Marrow failure. Hematology (Am Soc Hematol Educ Program) 2004(1):318-336.
2. Buchwald M, Carreau M (1999) Genetic basis of Fanconi anemia. Aplastic Anemia, eds Schrezenmeier H, Bacigalupo A (Cambridge Univ Press, Cambridge, UK), p 403.
3. Bogliolo M, et al. (2013) Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet 92(5):800-806.
4. Kashiyama K, et al. (2013) Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet 92(5):807-819.
5. Kee Y, D'Andrea AD (2012) Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 122(11):3799-3806.
6. Kaddar T, Carreau M (2012) Fanconi anemia proteins and their interacting partners: A molecular puzzle. Anemia 2012:425814.
7. Huard CC, et al. (2013) Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1. Blood 121(10):1729-1739.
8. Chinnadurai G (2007) Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol 39(9):1593-1607.
9. Shi Y, et al. (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422(6933):735-738.
10. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25(57):7469-7481.
11. Glinka A, et al. (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391(6665):357-362.
12. Mukhopadhyay M, et al. (2001) Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev Cell 1(3):423-434.
13. MacDonald BT, Adamska M, Meisler MH (2004) Hypomorphic expression of Dkk1 in the doubleridge mouse: Dose dependence and compensatory interactions with Lrp6. Development 131(11):2543-2552.
14. Adamska M, MacDonald BT, Meisler MH (2003) Doubleridge, a mouse mutant with defective compaction of the apical ectodermal ridge and normal dorsal-ventral patterning of the limb. Dev Biol 255(2):350-362.
15. Pinzone JJ, et al. (2009) The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113(3):517-525.
16. Alter BP (2003) Cancer in Fanconi anemia, 1927-2001. Cancer 97(2):425-440.
17. Fleming HE, et al. (2008) Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2(3): 274-283.
18. Alter BP, Joenje H, Oostra AB, Pals G (2005) Fanconi anemia: Adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg 131(7): 635-639.
19. Rosenberg PS, Socié G, Alter BP, Gluckman E (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105(1):67-73.
20. Carreau M, et al. (1999) Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol 27(11):1667-1674.
21. Haneline LS, et al. (1999) Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood 94(1):1-8.
22. Habi O, Delisle MC, Messier N, Carreau M (2005) Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion. Stem Cells 23(8):1135-1141.
23. Dao KH, et al. (2012) FANCL ubiquitinates β-catenin and enhances its nuclear function. Blood 120(2):323-334.
24. Semënov MV, Zhang X, He X (2008) DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem 283(31):21427-21432.
25. Du W, et al. (2012) The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters. Blood 119(18):4142-4151.
26. Park E, et al. (2013) FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. Mol Cell 50(6):908-918.
27. Matsushita N, et al. (2011) Direct inhibition of TNF-α promoter activity by Fanconi anemia protein FANCD2. PLoS ONE 6(8):e23324.
28. Gregory CA, Singh H, Perry AS, Prockop DJ (2003) The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278(30):28067-28078.
29. Li X, et al. (2003) Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control. Blood 102(6):2081-2084.
30. Tremblay CS, et al. (2008) HES1 is a novel interactor of the Fanconi anemia core complex. Blood 112(5):2062-2070.
31. Brodeur I, et al. (2004) Regulation of the Fanconi anemia group C protein through proteolytic modification. J Biol Chem 279(6):4713-4720.